Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

BioHarvest Sciences congratulates ‘Team VINIA’ NFL prospects on draft success

BioHarvest Sciences said all five athletes who entered this past weekend’s 2023 National Football League (NFL) Draft as members of “Team VINIA” were all either drafted or signed.

The company said the athletes prepared for the draft with Yo Murphy of the House of Athlete and used VINIA, the company’s red grape-based supplement, as part of their regimen.

The first of the group to be drafted was Tre Tucker, at 100th overall to the Las Vegas Raiders.

Tyler Scott was drafted by the Chicago Bears, Andrei Iosivas by the Cincinnati Bengals, Deuce Vaughn by the Dallas Cowboys, and Silas Dsanzi was signed as a free agent with the Tampa Bay Buccaneers.

The company’s CEO Ilan Sobel said the BioHarvest team looked forward to a continued relationship with these exciting NFL prospects and wished them luck and health in the NFL and beyond.

Further, the company announced that in the US it has seen 26,600 new customers make their first VINIA purchase in the past year, bringing its total US lifetime customer count to 32,300.

VINIA now has over 2,000 verified online reviews following the launch of the company’s first major 2023 marketing campaign “Real Stories” which is focused on how the supplement impacts customer’s lives. The reviews are averaging a 4.75 out of 5 rating.

"We're establishing VINIA as a leader in health supplements, backed by science, and now validated by thousands of verified customer reviews,” Sobel said in a statement.

“Our 2023 sales growth target is aggressive, and passing the 2,000-review mark is a significant milestone towards our goal of being a best-in-class wellness brand."

BioHarvest is a biotech firm that has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at an industrial scale, without the need to grow the plant itself.

Contact the author at emily.jarvie@proactiveinvestors.com

Follow her on Twitter @emilyjjarvie

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK